Article thumbnail

Formulation, In Vitro and In Vivo Pharmacokinetics of Anti-HIV Vaginal Bioadhesive Gel

By A Chatterjee, B B Bhowmik and Y S Thakur

Abstract

Inexpensive and female-controlled pre-exposure prophylaxis strategies to prevent mucosal transmission of the virus, is urgently needed with the rising prevalence of human immunodeficiency virus (HIV-1 and HIV2) infections in women. Zidovudine-loaded bioadhesive vaginal gel may become one of the very useful strategies, as it can be used not only for controlled release but also for enhancing bioavailability. Drug delivery through vaginal gel is a promising area for continued research with the aim of achieving controlled release with enhanced bioavailability over longer periods of time. The aim of the study was to develop a newer prolong releasing Zidovudine (AZT) bioadhesive vaginal gel to treat HIV infections with increased patient convenience. AZT-loaded bioadhesive vaginal gel was prepared successfully by using cold mechanical method. F3 formulation containing carbopol–HPMC (1:3) was selected and evaluated in order to achieve objectives of this study. In vitro drug release study of F3 showed in 24 h drug released following case I Fickian (n ≤ 0.5) transport mechanism, and in vivo drug release was found much better (Tmax), (Cmax), and bioavailability (F) comparison with oral pour drug solution. It was also showed good extrudability, spreadability, and bioadhesive strength. A generalized protocol, for the further research, in this area will surely expected to yield significant outcome with improved drug delivery system

Topics: Pharmaceutics
Publisher: Medknow Publications
OAI identifier: oai:pubmedcentral.nih.gov:3122051
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2005). Advancing vaginal drug delivery. Expert Opin Drug Deliv
  2. (2003). Antiviral drugs.
  3. Assessment of chitosan derivatives as buccal and vaginal penetration enhancers.
  4. Development and in-vitro evaluation of thermo reversible nasal gel formulations of Rizatriptan benzoate.
  5. Formulation and development of novel combined halobetasol propionate and fusidic acid ointment.
  6. Formulation, development and evaluation of Fluconazole gel in various polymer bases.
  7. In - vitro and in – vivo release of Zidovudine from different liposome gel in rabbit model.
  8. (1992). Measurement of bioadhesive strength of mucoadhesive buccal tablets. Indian Drugs
  9. Mechanism of rate of sustained action medication.
  10. Modern ointment bases technology–II – Comparative evaluation of bases.
  11. (2007). Organization, AIDS epidemic update global over view. Available from: http://data.unaids.org/pub/EPISlides/2007/2007_ epiupdate_en.pdf. [last cited in
  12. Pharmacokinetic and pharmacodynamic studies following percutaneous absorption of erythropoietin micropiles to rats.
  13. Preparation and in vitro characterization of slow release testosterone nanocapsules in alginates.
  14. Preparation and properties of Pluronic PF -127 gels for the treatment of bruns.
  15. Quantitative plasma determination of a novel anti-retroviral derivative of Zidovudine by solid – phase extraction and high – performance liquid chromatography.
  16. (1991). Release rate of Ketoprofen from polaxomer gels in a membrane less diffusion cell.
  17. Release rate of Tenoxicam from Acrypol gels.
  18. The Vagina as a route for the systemic drug delivery.
  19. Why cosider vaginal drug admistration.